State of Alaska Department of Revenue’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,130
| Closed | -$202K | – | 1648 |
|
|
2023
Q1 | $202K | Sell |
7,130
-121
| -2% | -$3.43K | ﹤0.01% | 1595 |
|
|
2022
Q4 | $211K | Sell |
7,251
-107
| -1% | -$3.11K | ﹤0.01% | 1592 |
|
|
2022
Q3 | $194K | Sell |
7,358
-1,091
| -13% | -$28.8K | ﹤0.01% | 1585 |
|
|
2022
Q2 | $375K | Buy |
8,449
+540
| +7% | +$24K | ﹤0.01% | 1468 |
|
|
2022
Q1 | $391K | Sell |
7,909
-140
| -2% | -$6.92K | ﹤0.01% | 1478 |
|
|
2021
Q4 | $409K | Sell |
8,049
-360
| -4% | -$18.3K | ﹤0.01% | 1528 |
|
|
2021
Q3 | $469K | Buy |
8,409
+335
| +4% | +$18.7K | ﹤0.01% | 1486 |
|
|
2021
Q2 | $345K | Buy |
8,074
+220
| +3% | +$9.4K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $327K | Sell |
7,854
-1,170
| -13% | -$48.7K | ﹤0.01% | 1546 |
|
|
2020
Q4 | $420K | Sell |
9,024
-2,300
| -20% | -$107K | ﹤0.01% | 1432 |
|
|
2020
Q3 | $481K | Buy |
11,324
+2,020
| +22% | +$85.8K | 0.01% | 1257 |
|
|
2020
Q2 | $446K | Sell |
9,304
-80
| -0.9% | -$3.84K | 0.01% | 1286 |
|
|
2020
Q1 | $431K | Buy |
9,384
+1,745
| +23% | +$80.1K | 0.01% | 1175 |
|
|
2019
Q4 | $458K | Sell |
7,639
-132
| -2% | -$7.91K | 0.01% | 1345 |
|
|
2019
Q3 | $439K | Buy |
7,771
+4,264
| +122% | +$241K | 0.01% | 1328 |
|
|
2019
Q2 | $195K | Buy |
3,507
+30
| +0.9% | +$1.67K | ﹤0.01% | 1464 |
|
|
2019
Q1 | $175K | Sell |
3,477
-240
| -6% | -$12.1K | ﹤0.01% | 1494 |
|
|
2018
Q4 | $149K | Buy |
3,717
+110
| +3% | +$4.41K | ﹤0.01% | 1499 |
|
|
2018
Q3 | $250K | Buy |
3,607
+905
| +33% | +$62.7K | ﹤0.01% | 1433 |
|
|
2018
Q2 | $204K | Hold |
2,702
| – | – | ﹤0.01% | 1479 |
|
|
2018
Q1 | $142K | Buy |
2,702
+1,010
| +60% | +$53.1K | ﹤0.01% | 1510 |
|
|
2017
Q4 | $90K | Hold |
1,692
| – | – | ﹤0.01% | 1535 |
|
|
2017
Q3 | $100K | Buy |
1,692
+100
| +6% | +$5.91K | 0.01% | 1181 |
|
|
2017
Q2 | $125K | Buy |
1,592
+702
| +79% | +$55.1K | 0.01% | 1048 |
|
|
2017
Q1 | $73K | Buy |
890
+30
| +3% | +$2.46K | 0.01% | 1036 |
|
|
2016
Q4 | $68K | Buy |
+860
| New | +$68K | 0.01% | 763 |
|